TECX
Tectonic Therapeutic, Inc.
There isn't enough reported data to score TECX yet.
TECX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Strong |
TECX's balance sheet is currently strong, but its profitability is under pressure. There isn't enough data to rate its revenue and cash flow.
TECX PE Valuation
TECX has no meaningful PE right now: it lost money over the past year.
TECX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| -- | |
| -- | |
| Limited | |
| High |
Analysts expect TECX's earnings, revenue and profitability to hold roughly steady.
TECX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$4.63 | -$0.47 |
| Q2 2026 | -$4.57 | -$0.23 |
| Q1 2026 | -$4.46 | +$3.15 |
| Q4 2025 | -$4.05 | +$4.43 |
| Q3 2025 | -$4.16 | +$5.58 |
| Q2 2025 | -$4.34 | +$9.96 |
| Q1 2025 | -$7.61 | -192% |
| Q4 2024 | -$8.48 | -362% |
TECX is still losing money, but far less than before: $4.63 per share over the past year, against $39.72 at its worst in late 2020.
TECX Quarterly Revenue
TECX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$14.9M | +$3.1M |
| Q2 2026 | -$21.5M | -$6.8M |
| Q1 2026 | -$18.4M | -$5.3M |
| Q4 2025 | -$14.5M | +$2.4M |
| Q3 2025 | -$18M | +$1.8M |
| Q2 2025 | -$14.7M | +$367K |
| Q1 2025 | -$13.1M | -$5.5M |
| Q4 2024 | -$16.8M | -$8.8M |
TECX has burned cash in almost every quarter: −$69M over the past year, against −$63M the year before.
TECX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +740K shares |
| 1 year | +5.3% | +991K shares |
| 3 years | +434% | +16M shares |
| 5 years | +555% | +16.7M shares |
TECX has 20M diluted shares, up 5.3% from a year ago.
TECX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2024 | -3.3x | Net Cash |
| Q4 2023 | -9.1x | Net Cash |
TECX has more cash than debt.
TECX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.0 | Neutral |
| Stochastic | 7.9 | Oversold |
TECX's weekly RSI is 39 (neutral) and its Stochastic is 8 (oversold).
TECX PE vs Healthcare Sector
| Metric | TECX | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
TECX has no meaningful PE right now: it lost money over the past year.
TECX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.5 | 2% below |
| 20 week MA | $28.1 | 25% below |
| 50 week MA | $27.0 | 22% below |
| 100 week MA | $25.8 | 19% below |
| 200 week MA | $22.3 | 5.7% below |
TECX is in a downtrend: it's below all five of its weekly moving averages, and 5.7% below its 200-week average.
TECX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $235.0 | $176.2 | -25% |
| 2021 | $176.2 | $46.9 | -73% |
| 2022 | $46.9 | $9.12 | -81% |
| 2023 | $9.12 | $16.3 | +79% |
| 2024 | $16.3 | $47.0 | +188% |
| 2025 | $47.0 | $20.9 | -56% |
| 2026 YTD | $20.9 | $21.0 | +0.8% |
TECX's yearly returns have swung widely, from +188% in 2024 to −81% in 2022. It's up 0.8% so far in 2026.